Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare BATS:ARKG BATS:HELX NYSEARCA:IDNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARKGARK Genomic Revolution ETF$33.41-7.9%$29.78$22.65▼$37.30$1.49B1.622.78 million shs4.37 million shsHELXFranklin Genomic Advancements ETF$34.80-2.6%$33.78$26.90▼$38.17$13.92M1.051,007 shs36 shsIDNAiShares Genomics Immunology and Healthcare ETF$29.14-2.7%$29.58$20.15▼$31.41$158.81M0.9640,812 shs39,694 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARKGARK Genomic Revolution ETF0.00%-3.55%+9.97%+18.81%+48.21%HELXFranklin Genomic Advancements ETF0.00%-1.78%+3.17%+5.87%+29.75%IDNAiShares Genomics Immunology and Healthcare ETF0.00%-2.48%-1.39%-1.49%+39.69%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARKGARK Genomic Revolution ETF$33.41-7.9%$29.78$22.65▼$37.30$1.49B1.622.78 million shs4.37 million shsHELXFranklin Genomic Advancements ETF$34.80-2.6%$33.78$26.90▼$38.17$13.92M1.051,007 shs36 shsIDNAiShares Genomics Immunology and Healthcare ETF$29.14-2.7%$29.58$20.15▼$31.41$158.81M0.9640,812 shs39,694 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARKGARK Genomic Revolution ETF0.00%-3.55%+9.97%+18.81%+48.21%HELXFranklin Genomic Advancements ETF0.00%-1.78%+3.17%+5.87%+29.75%IDNAiShares Genomics Immunology and Healthcare ETF0.00%-2.48%-1.39%-1.49%+39.69%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARKGARK Genomic Revolution ETF 2.56Moderate Buy$33.41N/AHELXFranklin Genomic Advancements ETF 2.81Moderate Buy$34.80N/AIDNAiShares Genomics Immunology and Healthcare ETF 2.57Moderate Buy$29.14N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARKGARK Genomic Revolution ETFN/AN/AN/AN/AN/AN/AHELXFranklin Genomic Advancements ETFN/AN/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARKGARK Genomic Revolution ETFN/AN/AN/AN/AN/AN/AN/AN/AN/AHELXFranklin Genomic Advancements ETFN/AN/A26.71N/AN/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AN/A14.76N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthARKGARK Genomic Revolution ETFN/AN/AN/AN/AN/AHELXFranklin Genomic Advancements ETFN/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETF$0.301.03%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARKGARK Genomic Revolution ETFN/AHELXFranklin Genomic Advancements ETFN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AInsider OwnershipCompanyInsider OwnershipARKGARK Genomic Revolution ETFN/AHELXFranklin Genomic Advancements ETFN/AIDNAiShares Genomics Immunology and Healthcare ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARKGARK Genomic Revolution ETFN/A44.70 millionN/ANot OptionableHELXFranklin Genomic Advancements ETFN/A400,000N/ANot OptionableIDNAiShares Genomics Immunology and Healthcare ETFN/A5.45 millionN/ANot OptionableARKG, HELX, and IDNA HeadlinesRecent News About These CompaniesiShares genomics immunology and healthcare ETF declares semi-annual distribution of $0.1554December 16, 2025 | msn.comIDNA: The Cutting Edge Of Medical Science Is A Risky InvestmentApril 20, 2025 | seekingalpha.com(IDNA) Trading SignalsDecember 26, 2024 | news.stocktradersdaily.comN(IDNA) Investment ReportDecember 4, 2024 | news.stocktradersdaily.comN(IDNA) Investment Analysis and AdviceNovember 23, 2024 | news.stocktradersdaily.comNDisruptive Theme of the Week – Breakthroughs in MedicineNovember 21, 2024 | etftrends.comEIshares Healthcare Innov Ucits Etf Acc Share Price (HEAL.MI)November 7, 2024 | lse.co.ukLearn to Evaluate (IDNA) using the ChartsNovember 2, 2024 | news.stocktradersdaily.comN(IDNA) On The My Stocks PageOctober 22, 2024 | news.stocktradersdaily.comN(IDNA) Pivots Trading Plans and Risk ControlsOctober 11, 2024 | news.stocktradersdaily.comN(IDNA) Technical Pivots with Risk ControlsOctober 1, 2024 | news.stocktradersdaily.comNiShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IUHC.L)September 25, 2024 | finance.yahoo.comWhen the Price of (IDNA) Talks, People ListenSeptember 20, 2024 | news.stocktradersdaily.comN(IDNA) Trading ReportAugust 24, 2024 | news.stocktradersdaily.comNiDNA Genomics Public LtdMay 18, 2024 | morningstar.comMiShares Genomics Immunology and Healthcare ETF (IDNA)April 15, 2024 | finance.yahoo.comIDNA: Healthcare Dashboard For FebruaryFebruary 18, 2024 | seekingalpha.comiShares Genomics Immunology and Healthcare ETFFebruary 1, 2024 | fxempire.comFiShares Genomics Immunology and Healthcare ETF declares semi-annual distribution of $0.1692December 22, 2023 | msn.comIBRN iShares Neuroscience and Healthcare ETFDecember 16, 2023 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 2026Before the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 20263 ETFs For the Coming Genomics RevolutionBy Nathan Reiff | June 7, 2026ARKG, HELX, and IDNA Company DescriptionsARK Genomic Revolution ETF BATS:ARKG$33.41 -2.86 (-7.89%) As of 06/5/2026 04:10 PM EasternThe ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.Franklin Genomic Advancements ETF BATS:HELX$34.80 -0.94 (-2.63%) As of 06/5/2026 04:10 PM EasternThe Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.iShares Genomics Immunology and Healthcare ETF NYSEARCA:IDNA$29.14 -0.82 (-2.74%) As of 06/5/2026 04:10 PM EasternThe iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/01 - 06/05 Samsara Just Answered The AI Question—Is Wall Street Ready To Listen? A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? IREN's 800MW Bet Flips the AI Power Switch Buy the Dip? Broadcom's AI Moat Is Wider Than Ever CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip? The Market Has Ollie’s Bargain Outlet Completely Wrong Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
